All posts by imreal

Technology: Electronics

nexVortex Cloud Communication Services Achieve HIPAA Compliance

Leave a comment


News Image


HERNDON, Va. (PRWEB)

nexVortex, a leader in high-quality cloud communications and an industry expert in both SIP Trunking and Hosted Voice, announced that their cloud communications portfolio has completed the HIPAA verification process as needed to meet Health Insurance Portability and Accountability Act standards for providers of communication services to healthcare professionals.

As more and more healthcare organizations move their communications to the cloud, they need to ensure they are working with a communications provider who is aware of the laws surrounding patient information and is committed to protecting patient privacy. A key component of HIPAA compliance for a healthcare organization is to ensure that their communications provider (defined as a “business associate”) has gone through the proper process and is able to provide the healthcare organization with a Business Associate Agreement (BAA).

nexVortex invested in and completed the compliancy certification process through a noted third-party organization and can provide healthcare professionals with a BAA upon request.

“Healthcare is an important vertical market for us,” said Ron Byer, nexVortex Director of Cloud Communications. “By investing in and achieving HIPAA compliance, we demonstrate to our healthcare customers that they are important to us, and we share in their responsibility to protect patient information.”

Channel partners or customers who require a BAA from nexVortex can contact us directly at +1.855.639.8888 or via email at sales@nexvortex.com.

About nexVortex

nexVortex has been delivering business cloud communication services for over 13 years and is an industry leader in SIP trunking, multisite applications, hosted voice, hosted contact centers, and customized solutions. Our award-winning Managed SIP (mSIP) and Managed Hosted Voice (mHV) services deliver Quality, Availability, and Visibility. mConnect, our SD-WAN service, builds on this legacy. nexVortex has established itself in the marketplace based on four overarching tenets: Uncommon Service, Uncommon Know-How, Uncommon Commitment, and Uncommon Innovation. These core principles and competencies drive nexVortex’s mission to provide its customers with the IP knowledge, services, and capabilities they need to improve their business communications. Visit http://www.nexVortex.com, follow us on social media, and learn how we can help you meet your business needs.

nexVortex Media Contact:

Chuck Harris

(571) 267-5774

charris@nexVortex.com

Share article on social media or email:

Society: Disabled Issues / Disabilities

Visionary Chris Olver Named Executive Director of Cerebral Palsy Alliance Research Foundation

Leave a comment


Chris Olver, Executive Director, Cerebral Palsy Alliance Research Foundation


NEW YORK (PRWEB)

Cerebral Palsy Alliance Research Foundation (CPARF) is thrilled to announce the appointment of Chris Olver as its new Executive Director. Chris is a nonprofit leader with proven fundraising and storytelling track records with mission-driven organizations on three continents.

“Chris brings a special medley of skills, longtime nonprofit experience, and passion that will serve us well as we continue to build CPARF into a global research leader in the cerebral palsy (CP) space, changing the lives of people with CP and the lives of those who care for and about them,” said CPARF’s Chairman, Jean-Louis Lelogeais, on behalf of the Board of Directors. “We are thrilled to have Chris join us.”

As a former filmmaker, development director, and executive leader, Chris is uniquely equipped to steer CPARF’s growth and narrative into the next exciting phase. He has spent the last five years serving as the Associate Executive Director of Ramapo for Children, a national education reform organization based in New York City.

Chris feels a deeply personal pull toward CPARF’s mission to advance cutting-edge research that will change the lives of 18 million people of all ages with CP. As the father to two young children who were born prematurely — one at 28 weeks and one at 29 weeks — Chris shared that he and his family, “have directly benefited from research into CP prevention and detection, including specific research-driven practices funded by CPARF.”

He is energized by this opportunity and says, “It’s incredibly humbling and inspiring to have the chance to use my professional experience and skills to continue to expand that research and our impact on people with CP.”

CP is the most common childhood-onset physical disability in the world, but it’s one of the most underfunded. CPARF aims to change that by carving a prominent place for CP in the national consciousness, and by funding and harnessing the forward momentum of CP research in several promising areas, including chronic pain treatment alternatives, thought-to-speech communication, and regenerative medicine.

CPARF’S MISSION

Cerebral Palsy Alliance Research Foundation won’t stop until people with CP can live pain-free, until they can live the lives they envision for themselves, and until they can express what’s on their mind and be understood even when they can’t communicate verbally. We won’t stop until we can prevent CP in the first place. We won’t stop until we find a cure.

We work with the best US-based scientists and foster nationwide and global collaboration between the brightest researchers. We ensure they can share their breakthroughs and advances with each other. As the only organization in the world solely focused on CP research, CPARF is poised to reshape the disability landscape. We’re poised to make breakthroughs. We are poised to change lives.

To learn more about CPARF’s funded research projects, visit http://www.cparf.org or contact info@cparf.org.

Share article on social media or email:

Lifestyle: Self Help

Beyond Publishing, a Global Media Company, Will be Hosting a ‘Twenty-Five-Plus Author Showcase’

Leave a comment


Beyond Publishing, a global media company, will be hosting a “twenty-five-plus author showcase” on November 14th at The Hyatt Place Hotel in Downtown St. Petersburg from 5:00 p.m. to 9:00 p.m.

Everyone has a story that needs to be told. We help them come to light and brighten the world.


ST. PETERSBURG, Fla. (PRWEB)

Publisher & CEO Michael D. Butler will be hosting this event to help Floridians explore the world of book writing. St. Petersburg’s own Forbes Riley & Amazing John John Humphreys will join over twenty-five authors from the USA and across the globe.

Floridians interested in writing a book or speaking can spend November 14th at an “open to the public” St. Petersburg, FL authors and speakers showcase. It is produced by Beyond Publishing, Inc., and nationally acclaimed publisher, and CEO Michael D. Butler.

November 14th, 2019 – St Petersburg, FL – “Twenty-Five-Plus Author Showcase”

The opportunity to learn from over twenty-five international speakers and authors comes to Tampa and St. Petersburg on Thursday, November 14th, from 5:00 p.m. to 9:00 p.m. at the Hyatt Place Hotel in downtown St. Petersburg. The general public and those interested in writing a book or becoming a public speaker can listen to messages, ideas, and ‘how-to’ discussions.

The Beyond Publishing “Twenty-Five-Plus Author Showcase” is centered on serving current and potential authors. Authors in attendance and speaking range from St. Petersburg’s own TV and Media darlings, The Amazing John John, the world’s youngest motivational speaker and author of BE AMAZING, and Forbes Riley, the Home Shopping Network Queen who has sold 2.5 billion of her own and others’ products on TV and now runs The Forbes Factor from her studio in St. Petersburg. Her new book, What Have You Forbes’d Lately is already #1 on Amazon. Other guests include Dr. Sonja Stribling, Dr. Ross Carter, and Dr. Dorian Williams.

Beyond Publishing authors have spoken in over 20 countries this year, and will speak in over 25 countries in 2020. Authors featured at the St. Pete event have been frequent guests on radio, television, podcasts, in print media and delivering keynotes ranging from business success, to entrepreneurial start up, to relationships, health, and money. Attendees will be delighted to meet this ensemble of authors from California, Michigan, Texas, Arizona, Kansas, Wisconsin, Kentucky, Illinois, Florida, and Georgia. In addition to the doctors and those previously mentioned are Daniel Gomez, Carl Merkle, Stan Padgett, Tom Chesser, Deb North, Denise O’Brien, Alan Asp, Bella Cruz, Shy Gold, Makeena Riley, Vale’ssa Winslow, Dan Snell, Dale Brunner, C. Ray Collins, Brandie Barclay, Joshua Self, Katie Chandler, and others.

This once-in-a-lifetime event begins Thursday morning from 9:30 to 11:00 at the local iFLY in Tampa where Tampa Author 11-year-old John John Humphreys will attempt a Guinness Book of World Record to be the first author to do a book signing while skydiving. Humphreys is challenging others to believe in their dreams and soar, no matter their age. Later, in the evening program, Humphreys will appear and discuss “How writing your book and speaking can start at any age.”

Information and tickets for Thursday’s event are available at https://beyondpublishing.net/FloridaAuthorEvent. Special student pricing is available, as Butler noted college students are some of the fastest-growing author success stories in America.

At a time when many people are looking for better ways to navigate through corporate America, political scenarios, financial struggles, and relationship questions, hundreds of new and seasoned authors are knocking on the door of Beyond Publishing with a story, a message, or wanting to share knowledge and encouragement with others. “Our authors, many of whom are writing their first book, are finding that a ‘hybrid publishing’ firm like Beyond Publishing offers the attention, the process, and the reasonable investment they are looking for,” noted Butler, who has represented authors in over 20 countries in the publishing industry.

https://youtu.be/yi1IOHGg0Fk

Corporate CEOs, personal development gurus, motivational speakers, customer service executives, and relationship experts are just some of the recent Amazon #1 bestsellers published by Beyond Publishing. Butler noted that he had served authors from age 8 to age 92 in his publishing journey. “Everyone has a story that needs to be told. We help them come to light and brighten the world,” said Butler.

BEYOND PUBLISHING

Beyond Publishing is a leading hybrid publishing company that offers full-service publishing, consulting, coaching, promotion, and speaker bureau services. Michael D. Butler, the CEO, has brought together a team of book launch experts who help authors write, create, and publish new books while assisting them in employing the latest in book launch strategies to maximize their book launch and increase their odds of winning at achieving Best Seller Status.

Share article on social media or email:

health and fitness

LIVFRESH Earns Coveted Spot as Best Toothpaste in GQs Magazine’s 2019 Grooming Awards – November Issue

Leave a comment


LIVFRESH Wintergreen Dental Gel

“We are thrilled to have LIVFRESH included as a 2019 GQ Grooming Awards’ winner in this magazine that is highly recognized as the leader in men’s grooming and fashion,” said Livionex CEO Amit Goswamy.


SAN FRANCISCO (PRWEB)

Today, Livionex announces its newly launched LIVFRESH dental gel line has earned a spot as one of the ‘41 Best Grooming Products for Men in 2019’ in GQ Magazine’s November Grooming Awards issue.

LIVFRESH was referred to as “The only useful thing to come out of Silicon Valley: a lightweight, investor-backed, science-y gel that makes teeth feel squeaky clean,” according the GQ Magazine article.

“We are thrilled to have LIVFRESH included as a 2019 GQ Grooming Awards’ winner in this magazine that is highly recognized as the leader in men’s grooming and fashion,” said Livionex CEO Amit Goswamy.

“Research has shown that men have a higher incidence of periodontal disease than women. We couldn’t be happier that GQ recognizes just how critical it is that their readers implement a preventative dental care routine. Our LIVFRESH line is dentist-recommended as well as clinically proven, in published studies, to clean teeth and remove plaque (the root cause of periodontal disease), 250% better than the leading brands,” added Goswamy.

The LIVFRESH line includes LIVFRESH Peppermint, LIVFRESH Wintergreen and LIVFRESH Mild Peppermint. All three gels use 100% edible ingredients to eliminate bad breath, prevent tartar formation, and re-mineralize enamel.

What’s different about LIVFRESH, than other toothpastes, is that it uses activated edathamil in a new technology that removes plaque from the teeth at the molecular level. Additionally, LIVFRESH doesn’t use abrasives, antimicrobials, and parabens found in major toothpaste brands; as a result, it is safe for all ages including young children and pregnant women. The products are cruelty-free, gluten-free, and vegan.

The plaque-disrupting technology underlying LIVFRESH has been validated by numerous sources, including dental professionals, the U.S. Department of Defense, and the National Institutes of Health .

For more information, please visit GetLIVFRESH.com.

About LIVIONEX

Livionex was founded in 2009 by Stanford and Berkeley alums with the goal of enhancing the quality and longevity of human life. Headquartered in Los Gatos, CA, Livionex develops novel therapies for a variety of age-related diseases affecting billions of people worldwide. The Company’s products are based on its proprietary technology that modulates metal ions that cause oxidative stress and disease. The Company is introducing a new category of treatment for various disorders and diseases associated with metallo lipid protein aggregates, inflammation, and/or bacterial biofilms across ophthalmology, dermatology and oral care. Livionex recently accepted $4 million in Series A funding at a $180-million valuation to further accelerate the market penetration of its dental gel line. LIVFRESH Dental Gel is currently available on-line at GetLIVFRESH.com and in dental offices across the country.

Share article on social media or email:

Industry: Healthcare

Stigma-Free Talk about Skin STDs

Leave a comment


Dr. Sonoa Au

Most STIs are treatable and catching an infection early can prevent more serious complications. The dermatologist’s office is a valuable resource, as many STIs have skin symptoms.


RIDGEWOOD, N.J. (PRWEB)

“One aspect of the challenge of sexually transmitted infections (STIs) is the stigma,” notes Dr. Sonoa Au, a dermatologist with Advanced Dermatology PC. “But consensual sexual activity, which is a natural part of adult life, involves intimate contact that can spread infection. And millions of people get STIs every year.”

Make that about 20 million new cases a year, according to the CDC, including infections such as gonorrhea, syphilis, chlamydia — and genital herpes.

In terms of genital herpes, the American Sexual Health Association states that as many as one out of five people is infected, usually with the “simplex two” form of the virus (HSV-2).

Genital herpes, as well as other STIs such as syphilis and HPV (the human papillomavirus), can be transmitted via skin-to-skin contact.

“Condoms are effective at blocking transmission of fluid-borne STIs, like chlamydia, HIV, and gonorrhea,” explains Dr. Au. “But with infections that are transmitted via the skin, while condoms can help, they won’t block infection from an uncovered area.”

“Increasing openness and awareness is crucial,” continues Dr. Au. “Most STIs are treatable and catching an infection early can prevent more serious complications. The dermatologist’s office is a valuable resource, as many STIs have skin symptoms.”

Organizations such as the American Sexual Health Association and The STI Project (also founded by the Herpes Activist Network’s Pierce) are making important inroads in providing resources and support.

“In terms of stigma,” observes Dr. Au, “genital herpes, in particular, triggers anxiety because it is what we call a ‘recurrent’ infection: once a person has it, they have it for life.”

In this regard, HSV-2 is similar to its oral relative, the “simplex one” form of the virus (HSV-1), which can cause cold sores and fever blisters. About half of adults have HSV-1, typically the result of non-sexual childhood exposure, for example from a relative’s kiss. “Like HSV-1, genital herpes is also usually mild and manageable,” says Dr. Au. “So much so that a person may not even know they have it. Some are not symptomatic. And mild outbreaks can easily be attributed to other causes, like an insect bite.”

To increase awareness and reduce stigma regarding genital herpes, Dr. Au offers the following advice:

5 Tips for Understanding Genital Herpes:

1. See your doctor if you’re worried: “Different tests have distinct parameters,” explains Dr. Au. “If you notice a skin abnormality – a sore, a blister or a pimple – this can be swabbed and checked. DNA testing of the swabbed sample is the most accurate choice. In the absence of symptoms, a blood test for IgG antibodies can detect long-term infections.”

2. Positive results? There are management options: “For patients with regular outbreaks, there are effective means of limiting frequency,” says Dr. Au. “For example, daily anti-viral medications such as valacyclovir pills can reduce outbreaks by at least 75 percent.”

3. Be aware of symptomless transmission: “One challenge with HSV-2 is that at certain times the virus is present on the skin even though there is no visible outbreak,” states Dr. Au. “Skin-to-skin contact at such times can transmit the infection. Condoms can limit the extent of skin exposure. And daily anti-viral medications seem to decrease risk.”

4. Pregnant? Ensure a safe delivery: “Pregnant women can be tested for genital herpes because an outbreak is a health risk during delivery,” notes Dr. Au. “Those who know they have the virus should inform their doctor. In most cases, there is no impact on the delivery, but if there is an outbreak at that time, many doctors will advise for a C-section to protect the baby from serious health problems.”

5. Oral sex can cause genital infections: “With genital herpes, we usually think HSV-2,” observes Dr. Au. “But oral sex can transmit HSV-1 to the genitals. Awareness can guide people’s choices.”    

“Genital herpes may not have a celebrity spokesperson,” concludes Dr. Au. “But a lot of regular people have it, and they’re leading full and happy lives.”

Sonoa Au, MD, is a board-certified physician and a fellow of the American Academy of Dermatology

Advanced Dermatology P.C. and the Center for Laser and Cosmetic Surgery (New York & New Jersey) is one of the leading dermatology centers in the nation, offering highly experienced physicians in the fields of cosmetic and laser dermatology as well as plastic surgery and state-of-the-art medical technologies. http://www.advanceddermatologypc.com.

Share article on social media or email:

Business: Executives

Glewed TV Names V Paul Coyne CEO

Leave a comment


News Image

Paul’s appointment is a major milestone in Glewed TV’s aggressive growth and expansion plans


NEWARK, Del. (PRWEB)

Glewed TV, a leading video on demand (VOD) discovery, distribution and monetization management platform for original and professionally produced video content, today announced it has appointed V Paul Coyne as Chief Executive Officer (CEO). Coyne joins Glewed TV with extensive experience that spans more than three decades with a concentration on bringing emerging digital and media technology in the form of new product introductions and partnerships to the entertainment industry.

“Paul’s appointment is a major milestone in Glewed TV’s aggressive growth and expansion plans,” said Dean Marco, Chief Marketing Officer. “The Glewed TV team deserves to celebrate this news as Paul is a significant hire that gives immediate credibility to the company with his stellar industry reputation. I’m tremendously excited about the positive impact Paul will have taking our business to the next level while continuing in our mission to exceed our customers’ expectations.”

Prior to joining Glewed TV, Coyne was a Senior Vice President at Warner Music Group where he harnessed the new digital technology forces redefining music for both artists and labels. Prior to that, he was Chief Technology Officer at NBC where he worked closely with NBC Sports on three Olympic Games. His career also includes stints at IBM in conjunction with the prestigious TJ Watson Research Center and Lotus Development. In addition to the corporate world, Paul’s passion project was building the deal between WME owned IMG to fund the motorsports series Formula Drift where he remains part owner as they end their 16th season.

Commenting on his appointment, Coyne stated, “Glewed TV has already achieved great success sourcing high-value content for viewers looking for something different. I’m honored to be joining Glewed TV team at such a pivotal time for the company and look forward to building upon and sharing this success to the benefit of consumers, content creators and advertisers.”

With Glewed TV, video content creators are building audiences across all of the top OTT platforms –– Roku, Fire TV, and Apple TV — and discovering new revenue streams, while consumers are getting free access to premium on-demand TV programs that are unique, engaging, immediate and convenient.

By using Glewed TV’s extensive marketing, data and analytic services, brands are able to tell their story, reach and provide value added experiences and interactions for their target audiences.

Coyne concluded, “Video viewers want free content and as a result expect to see ads in exchange. Ad supported content is here to stay and Glewed TV is in a formidable position to lead and innovate the way viewers consume and pay for content.”

About Glewed TV

Glewed TV is one of the ways cord cutters are saving with free access to premium on-demand content. No subscription fees are required to watch movies and TV programs that are unique, engaging, immediate and convenient. Glewed TV is ad-supported and free across all platforms. Glewed TV sources and produces content of high production value with over 7,000 hours available. Main content categories include food, children, sports, DIY, educational, documentaries, animals/wildlife, travel, comedy, product reviews and movies.

Glewed TV was founded by a team of creators and technologists that have successfully launched and sold over 40 OTT/CTV channels in the past five years. Glewed TV knows exactly how to build channels for every CTV platform, reach and influence the right consumers with high quality and engaging content.

Share article on social media or email:

Health

DocASAP Wins The 2019 eHealthcare Leadership Awards for “Best Online Appointment Scheduling”

Leave a comment


News Image

“DocASAP is honored to be recognized as one of the healthcare industry’s leading technology providers for our innovative online appointment scheduling solution that’s part of our patient access and engagement platform,” said Puneet Maheshwari, co-founder and CEO of DocASAP.


HERNDON, Va. (PRWEB)

DocASAP, the most advanced patient access and engagement platform for health systems, health plans and physician groups, today announced it was selected as a winner of the 2019 eHealthcare Leadership awards program, under the Online Appointment Scheduling category. The annual nation-wide awards program distinguishes the top websites and digital initiatives in the healthcare industry.

“DocASAP is honored to be recognized as one of the healthcare industry’s leading technology providers for our innovative online appointment scheduling solution that’s part of our patient access and engagement platform,” said Puneet Maheshwari, co-founder and CEO of DocASAP. “DocASAP is dedicated to enhancing the patient experience and providing seamless access to world-class healthcare. This award further underscores our commitment to optimizing access to care by navigating patients to the right provider and care setting at the right time.”

DocASAP’s platform helps health systems, health plans and physician groups navigate patients and health plan members to optimal care throughout the healthcare journey to help improve outcomes, reduce costs and create a better experience. DocASAP’s provider search and navigation solution helps streamline access to care by matching patient demographics, insurance, clinical and timely care needs with provider credentials and availability. It handles the complexities of patient-provider matching by automating provider-specific scheduling intake rules, protocols and workflows.

DocASAP’s online scheduling solution facilitates real-time, accurate online appointment scheduling and integrates with practice management systems, helping deliver the frictionless access consumers demand. It now also accommodates non-traditional visit types, such as telehealth/virtual appointments, walk-ins, home visits and phone appointments.

Additionally, DocASAP’s recently launched point of care and access center capabilities to optimize care coordination across the enterprise, helping improve efficiencies and enhance the patient experience. DocASAP’s care-driven reminder solutions enables healthcare providers to engage patients pre and post-visit to encourage proactive and coordinated care management, helping close gaps in care and reduce no shows.

The “eHealthcare Leadership” awards program draws more than 1,000 entries a year and exclusively recognizes the very best websites and digital communications of healthcare organizations, online health companies, pharmaceutical/medical equipment firms, agencies/suppliers and business improvement initiatives. Presented by both eHealthcare Strategy & Trends Magazine and Strategic Health Care Marketing Magazine, the awards program highlights the role of digital communications in achieving healthcare organizations’ business objectives.

To view the full list of 2019 “eHealthcare Leadership” award winners, visit: https://ehealthcareawards.com/2019-winners/

About DocASAP

DocASAP provides the leading patient access and engagement platform for health systems, health plans and physician groups. The platform addresses one of healthcare’s biggest challenges – access to care – by helping navigate patients and members to the right provider and care setting at the right time. Backed and promoted in the market by Aetna and UnitedHealthcare, DocASAP builds unique payer-provider connections with an eye towards simplified access, increased care compliance and improved population risk management. DocASAP’s provider search and navigation, consumer-facing and access center scheduling, provider data management and care driven reminders help optimize access throughout the healthcare journey to improve outcomes, reduce costs and create a better experience. For more information, visit http://docasap.com or follow on Twitter @DocASAP.

Share article on social media or email:

Science: Biology

Mesa Science Associates and Bryn Pharma Announce Initial Study of a New Approach to Treating Anaphylaxis

Leave a comment


News Image


FREDERICK, Md. (PRWEB)

On November 10, 2019, Mr. Michael Mesa, President, and CEO of Mesa Science Associates (MSA), announced the presentation of a non-clinical study regarding Nasal Administration of Epinephrine. The results were presented by Kenneth Dretchen Ph.D., CSO and Principle Investigator at MSA. The study was presented in a poster at the American College of Allergy, Asthma, and Immunology (ACAAI) annual conference in Houston, Texas on November 10, 2019. The poster entitled, “Intranasal Effects on Pharmacokinetics and Heart Rate in a Nasal Congestion Canine Model” is the first in a series of publications to be presented by MSA that detail the results of non-clinical studies conducted to support the concept of Nasal Administration of Epinephrine for patients suffering from a severe allergic reaction, commonly known as anaphylaxis. MSA and MRI Global of Kansas City, MO. collaborated on the study which was funded by Bryn Pharma LLC. The study was conducted to determine the ability of epinephrine to be absorbed through the nasal mucosa and to determine blood levels and pharmacokinetic values when the drug is applied nasally to dogs that have nasal congestion. The nasal congestion was induced by continuous exposure to histamine throughout the test period. This study has shown that even with nasal congestion present the nasal route of administration of epinephrine in canines produce even higher plasma levels of the drug as compared to the intramuscular route of administration.

The current therapy to treat an anaphylactic event is the administration of epinephrine by intramuscular injection via an auto-injector. While this treatment has shown to be effective, problems with auto-injectors include patient concerns about needles that can lead to avoidance, delayed therapy, or even injury at the injection site. Bryn Pharma, a North Carolina based company, is developing a new cost-effective two-dose nasally administered therapy that has the potential to mitigate most of the issues with autoinjector administration. The device is a small compact unit that is needle-free and easy to carry in pockets or purses. MSA is under contract to support the Bryn effort through commercial launch.

Mesa Science Associates is a pharmaceutical product development company located inside the Frederick Innovation and Technology Center Inc. (FITCI) in Frederick MD. The goal of the company is to provide technical and scientific expertise to researchers from all aspects of the drug, drug delivery and product development community, including researchers from the government, academia, and private entities.

Share article on social media or email:

Technology: Electronics

Ushio America Introduces the Theia™ Series, an Illuminator and Video Processor System for Microendoscopy Applications

Leave a comment


Theia Microendoscopy System

Theia Microendoscopy System

Available in a 40k-pixel and 160k-pixel resolution model, the system includes crisp and vibrant color images in the hardest to reach locations by matching some of the highest resolution CMOS cameras with the smallest videoscope sizes available.


VERGENNES, Vt. (PRWEB)

Ushio America, Inc. proudly introduces the Theia™ series, a combined illuminator and video processor system for research and original equipment manufacturers (OEMs) in microendoscopy applications. Available in a 40k-pixel and 160k-pixel resolution model, the system includes crisp and vibrant color images in the hardest to reach locations by matching some of the highest resolution CMOS cameras with the smallest videoscope sizes available. The video processor is capable of handling massive image and digital signal processing applications using a field-programmable gate array (FPGA).

The Theia 40 model has an active image sensor of 200µm x 200µm producing 40k-pixel resolution with a 3-50mm depth of focus and it is deal for 1.1mm outside diameter (OD) flexible endoscope and 2-6mm steerable endoscope applications. The Theia 40 automatically adjusts the LED output to maintain a properly illuminated image. The Theia 160 model has an active image sensor of 400µm x 400µm producing 160k-pixel resolution with a 5-50mm depth of focus. The Theia 160 video processor has auto-gain and auto-exposure, and it is ideal for flexible endoscopes 1.7mm OD or larger and 3-6mm steerable endoscope applications.

Both standard models have video output of 30 frames per second (fps), and the standard 6500K color temperature LED delivers uniform white light with up to four fibers surrounding a videoscope with 120º field of view (FOV). Additional product customizations are available including a wide array of endoscope diameters, rigid or flexible scopes, and a range of endoscope lengths.

For more information on the Theia series, visit http://www.ushio.com/medical-systems/ or call +1.802.877.2182.

About Ushio America, Inc.

Ushio America, Inc. is a vertically integrated solutions company for lighting systems and components utilizing xenon short arc, lasers, ultra-high-pressure UV, excimer, metal halide, LEDs (specialty sensing and architectural lighting), halogen, fluorescent, and miniature incandescent lamps serving semiconductor, printed circuit, video projection, cinema, medical, life sciences, UV curing, germicidal, horticulture, landscaping, graphic arts, flashlight, scientific, medical, infra-red heating, lamp and laser drivers, systems and services, and numerous other applications. Established in 1967 as a subsidiary of Ushio Inc., in Tokyo, Japan, Ushio America offers a full spectrum of over 2,500 products and services to its customers. For more information, visit http://www.ushio.com.

Share article on social media or email:

Industry: Healthcare

Greenberg Traurig’s David J. Dykeman Co-Chairs CJP Health Professions Annual Breakfast

Leave a comment



BOSTON (PRWEB)

David J. Dykeman, patent attorney and co-chair of Greenberg Traurig, LLP’s global Life Sciences & Medical Technology Group and Boston Intellectual Property & Technology (IP) Group will co-chair the Combined Jewish Philanthropies (CJP) Health Professions Annual Breakfast, Nov. 17 at 9:00 a.m. at the Royal Sonesta Boston. Greenberg Traurig is a sponsor of the event.

The event, which is co-chaired by Rachel Wolfberg, Pharm.D., Dana-Farber Cancer Institute, brings together medical professionals, senior executives, entrepreneurs, and investors from across the biotech, pharma, healthcare, medtech, and diagnostics industries to strengthen business relationships within the Greater Boston Jewish community. Keynote speaker Adam M. Koppel, M.D., Ph.D., Managing Director, Bain Capital Life Sciences, will discuss, “How Innovation is Improving Delivery of Medical Care — Creating Value for Patients and Investors.” In addition, attendees will honor Beverly Siegal, M.D., M.P.H. with The Lewis H. Millender Community of Excellence Award.

Prior to the breakfast, Dykeman, who also serves as the Healthcare Innovations Network (HIN) Chair, will host a special HIN pre-reception at 8:00 a.m. Guest speaker Sophie Kornowski, Pharm.D., MBA and Senior Partner, Gurnet Point Capital, will discuss “An Insider’s View on Dealmaking in Pharma and Biotech Ventures.”

About Greenberg Traurig’s Life Sciences & Medical Technology Group: Greenberg Traurig’s Life Sciences & Medical Technology Group advises clients ranging from start-ups to large multinational public companies to leading research institutions. The group’s attorneys work closely with clients, providing innovative legal counsel to help them achieve their objectives – from discovery through commercialization and product marketing.

About Greenberg Traurig: Greenberg Traurig, LLP (GT) has approximately 2100 attorneys in 41 locations in the United States, Latin America, Europe, Asia, and the Middle East. GT has been recognized for its philanthropic giving, diversity, and innovation, and is consistently among the largest firms in the U.S. on the Law360 400 and among the Top 20 on the Am Law Global 100. Web: http://www.gtlaw.com Twitter: @GT_Law

Share article on social media or email: